Style | Citing Format |
---|---|
MLA | Pouyan A, et al.. "Glioblastoma Multiforme: Insights Into Pathogenesis, Key Signaling Pathways, and Therapeutic Strategies." Molecular Cancer, vol. 24, no. 1, 2025, pp. -. |
APA | Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A, Mokhtari K, Shahpasand K, Farahani N, Meybodi TE, Entezari M, Taheriazam A, Hushmandi K, Hashemi M (2025). Glioblastoma Multiforme: Insights Into Pathogenesis, Key Signaling Pathways, and Therapeutic Strategies. Molecular Cancer, 24(1), -. |
Chicago | Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A, Mokhtari K, et al.. "Glioblastoma Multiforme: Insights Into Pathogenesis, Key Signaling Pathways, and Therapeutic Strategies." Molecular Cancer 24, no. 1 (2025): -. |
Harvard | Pouyan A et al. (2025) 'Glioblastoma Multiforme: Insights Into Pathogenesis, Key Signaling Pathways, and Therapeutic Strategies', Molecular Cancer, 24(1), pp. -. |
Vancouver | Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A, et al.. Glioblastoma Multiforme: Insights Into Pathogenesis, Key Signaling Pathways, and Therapeutic Strategies. Molecular Cancer. 2025;24(1):-. |
BibTex | @article{ author = {Pouyan A and Ghorbanlo M and Eslami M and Jahanshahi M and Ziaei E and Salami A and Mokhtari K and Shahpasand K and Farahani N and Meybodi TE and Entezari M and Taheriazam A and Hushmandi K and Hashemi M}, title = {Glioblastoma Multiforme: Insights Into Pathogenesis, Key Signaling Pathways, and Therapeutic Strategies}, journal = {Molecular Cancer}, volume = {24}, number = {1}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Pouyan A AU - Ghorbanlo M AU - Eslami M AU - Jahanshahi M AU - Ziaei E AU - Salami A AU - Mokhtari K AU - Shahpasand K AU - Farahani N AU - Meybodi TE AU - Entezari M AU - Taheriazam A AU - Hushmandi K AU - Hashemi M TI - Glioblastoma Multiforme: Insights Into Pathogenesis, Key Signaling Pathways, and Therapeutic Strategies JO - Molecular Cancer VL - 24 IS - 1 SP - EP - PY - 2025 ER - |